Login / Signup

Risk-score based strategy to minimize antibiotic exposure in children with sickle cell disease and fever.

Elena María Rincón-LópezMaría Luisa Navarro GómezTeresa Hernández-Sampelayo MatosDavid Aguilera-AlonsoEva Dueñas MorenoJosé María Bellón CanoJesús Saavedra-LozanoMaría Del Mar Santos SebastiánMarina García MorínCristina Beléndez BielerJorge Lorente RomeroElena Cela de Juliánnull null
Published in: Infection (2021)
Severe bacterial infections (SBI) have become less frequent in children with sickle cell disease (SCD) in the last decades. However, because of their potential risk of SBI, they usually receive empirical therapy with broad-spectrum antibiotics when they develop fever and are hospitalized in many cases. We performed a prospective study including 79 SCD patients with fever [median age 4.1 (1.7-7.5) years, 78.5% males; 17 of the episodes were diagnosed with SBI and 4 of them were confirmed] and developed a risk score for the prediction of SBI. The optimal score included CRP > 3 mg/dl, IL-6 > 125 pg/ml and hypoxemia, with an AUC of 0.91 (0.83-0.96) for the prediction of confirmed SBI and 0.86 (0.77-0.93) for possible SBI. We classified the patients in 3 groups: low, intermediate and high risk of SBI. Our risk-score-based management proposal could help to safely minimize antibiotic treatments and hospital admissions in children with SCD at low risk of SBI.
Keyphrases
  • young adults
  • end stage renal disease
  • chronic kidney disease
  • newly diagnosed
  • stem cells
  • prognostic factors
  • climate change
  • drug induced